Myriad Genetics
Myriad Genetics develops and sells molecular diagnostic and genetic tests that assess disease risk, inform diagnosis, and guide treatment for clinicians and patients across oncology, women’s health, and mental health. Its portfolio includes hereditary cancer screening, prenatal carrier screening, tumor profiling, and pharmacogenomic tests, delivered through healthcare providers and payer-reimbursed lab services with EMR integrations. Founded in 1991 and headquartered in Salt Lake City, it is a public company listed on NASDAQ.
Open Positions at Myriad Genetics
1 open position
Interface Engineer III leads complex EMR interoperability implementations that automate electronic orders and results between Myriad and external healthcare providers. The role combines Mirth-based interface development, data transformation, troubleshooting, client support, and technical leadership.